Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth J Davis

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
The American Journal of Managed Care|February 26, 2011
Healthcare costs and nonadherence among chronic opioid usersHarry L Leider, Jatinder Dhaliwal, Elizabeth J Davis, et al.
Cancer|May 21, 2014
Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort studyElizabeth J Davis, Jennifer L Beebe-Dimmer, Cecilia L Yee, et al.
Plant Physiology and Biochemistry : PPB|November 26, 2008
Searching for new cell wall protein genes in ArabidopsisElizabeth J Davis, Dong Chen, Daryll B Dewald, et al.
JACC. Cardiovascular Interventions|July 12, 2023
Hypoechoic Halo Imaging Findings Following Femoropopliteal Artery Stent Implantation: Risk Factors and Clinical OutcomesAndrew Holden, Yann Gouëffic, William A Gray, et al.
Cancer|May 29, 2020
Outcomes after progression of disease with anti-PD-1/PD-L1 therapy for patients with advanced melanomaJames R Patrinely, Laura X Baker, Elizabeth J Davis, et al.
Journal of Experimental Botany|June 29, 2006
Mutant identification and characterization of the laccase gene family in ArabidopsisXiaoning Cai, Elizabeth J Davis, Jenny Ballif, et al.
American Journal of Clinical Oncology|November 5, 2015
A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary CancersElizabeth J Davis, Kent A Griffith, Edward J Kim, et al.
JAMA Oncology|April 19, 2019
Association of Anti-Programmed Cell Death 1 Cutaneous Toxic Effects With Outcomes in Patients With Advanced MelanomaHenry T Quach, Anna K Dewan, Elizabeth J Davis, et al.
Expert Review of Anticancer Therapy|August 19, 2025
Desmoid tumor control with liposomal doxorubicin: a dual-center retrospective analysisVictoria Wytiaz, Rodney Dixon Dorand, Sean Cohen, et al.
Cancer|October 4, 2019
Health care utilization and steroid-refractory toxicities from immune checkpoint inhibitorsLaura X Wang, Henry T Quach, Nikil V Moodabigil, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
The American Journal of Managed Care|February 26, 2011
Healthcare costs and nonadherence among chronic opioid usersHarry L Leider, Jatinder Dhaliwal, Elizabeth J Davis, et al.
Cancer|May 21, 2014
Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort studyElizabeth J Davis, Jennifer L Beebe-Dimmer, Cecilia L Yee, et al.
Plant Physiology and Biochemistry : PPB|November 26, 2008
Searching for new cell wall protein genes in ArabidopsisElizabeth J Davis, Dong Chen, Daryll B Dewald, et al.
JACC. Cardiovascular Interventions|July 12, 2023
Hypoechoic Halo Imaging Findings Following Femoropopliteal Artery Stent Implantation: Risk Factors and Clinical OutcomesAndrew Holden, Yann Gouëffic, William A Gray, et al.
Cancer|May 29, 2020
Outcomes after progression of disease with anti-PD-1/PD-L1 therapy for patients with advanced melanomaJames R Patrinely, Laura X Baker, Elizabeth J Davis, et al.
Journal of Experimental Botany|June 29, 2006
Mutant identification and characterization of the laccase gene family in ArabidopsisXiaoning Cai, Elizabeth J Davis, Jenny Ballif, et al.
American Journal of Clinical Oncology|November 5, 2015
A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary CancersElizabeth J Davis, Kent A Griffith, Edward J Kim, et al.
JAMA Oncology|April 19, 2019
Association of Anti-Programmed Cell Death 1 Cutaneous Toxic Effects With Outcomes in Patients With Advanced MelanomaHenry T Quach, Anna K Dewan, Elizabeth J Davis, et al.
Expert Review of Anticancer Therapy|August 19, 2025
Desmoid tumor control with liposomal doxorubicin: a dual-center retrospective analysisVictoria Wytiaz, Rodney Dixon Dorand, Sean Cohen, et al.
Cancer|October 4, 2019
Health care utilization and steroid-refractory toxicities from immune checkpoint inhibitorsLaura X Wang, Henry T Quach, Nikil V Moodabigil, et al.
Pageof 5